Aparito

Company profile

Aparito company profile

Aparito’s mission is to digitise clinical trials and accelerate drug development by supporting patient-centric clinical trials with the Atom5™ eCOA platform. The Atom5™ platform is Part 11, GDPR and HIPPA compliant and supports clinical trials at scale with video eCOAs, ePROs, Wearables, Telemedicine and eConsent in 193 countries and 125 languages to capture more frequent patient-generated data in the clinic and at home. This moves from relying on sterile, snapshot assessments during clinic visits to continuous, real-time, real-world data utilising novel eCOA and digital biomarkers.